Advertisement
Diagnostics
Subscribe to Diagnostics
View Sample

FREE Email Newsletter

MEMS devices proliferate in the medical market

February 28, 2013 9:48 am | by Digi-Key Corporation | News | Comments

As the utilization of MEMS continues to grow across various industry sectors, commercial successes like the use of STMicroelectronics’ PCR chips in drug delivery; Boehringer Ingelheim’s success with MEMS-based inhalers; and the microfluidic chips used in Abbott’s blood gas analyzers are helping to drive a growing demand for MEMS devices in the medical market.

T2 Biosystems Announces Patent Covering In Vivo Application of Direct Detection Technology

February 28, 2013 9:00 am | by The Associated Press | News | Comments

LEXINGTON, Mass.--(BUSINESS WIRE)--Feb 28, 2013--T2 Biosystems, a company developing direct detection products enabling superior diagnostics, today announced the U.S. Patent and Trademark Office has issued patent 8,368,402 (the ‘402 patent), “NMR systems for in vivo detection of analytes”.

Cognoptix begins pre-pivotal clinical trial of its drug/device test designed to identify Alzheimer’s disease via beta amyloid signature in the eyes

February 28, 2013 8:30 am | by The Associated Press | News | Comments

ACTON, Mass.--(BUSINESS WIRE)--Feb 28, 2013--Cognoptix announced today that it has begun a 40-patient clinical trial of its SAPPHIRE II eye test designed to identify Alzheimer’s disease patients via a beta amyloid (“Ab”) signature in their eyes. By detecting a specific fluorescent signature of...

Advertisement

NanoString Expands Leadership Team With the Hiring of Two Seasoned Executives

February 28, 2013 7:30 am | by The Associated Press | News | Comments

SEATTLE--(BUSINESS WIRE)--Feb 28, 2013--NanoString Technologies, Inc., a privately held provider of life science tools for translational research and molecular diagnostic products, today announced the appointment of Gary S. Riordan as Vice President of Quality and Regulatory Affairs and Kathy...

John Muir Health Pilots Early Warning System For Heart Attack Patients

February 27, 2013 12:58 pm | by The Associated Press | News | Comments

WALNUT CREEK, Calif.--(BUSINESS WIRE)--Feb 27, 2013--Reducing the time it takes heart attack patients to receive treatment significantly increases their chances of survival and minimizes long-term damage to the heart and brain. John Muir Health’s Clinical Research Center recently began a clinical...

Quotient Biodiagnostics Raises Further $5.0 Million of Growth Finance Led by Paul Cowan and Galen Partners

February 26, 2013 9:59 am | by The Associated Press | News | Comments

EDINBURGH, Scotland & NEWTOWN, Pa.--(BUSINESS WIRE)--Feb 26, 2013--Quotient Biodiagnostics (“Quotient”), a global transfusion diagnostics group, is pleased to announce that its shareholders have invested a further $5.0 million in the company. Over the past 18 months Quotient has raised over...

LabCorp Launches Next Generation Sequencing Assay for Familial Cardiac Disease

February 25, 2013 8:45 am | by The Associated Press | News | Comments

BURLINGTON, N.C.--(BUSINESS WIRE)--Feb 25, 2013--Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) today announced it has launched its clinical next generation sequencing assay, GeneSeq®: Cardio for genetic causes of familial cardiac disease. Familial cardiac diseases are...

CardioDx to Present at Cowen and Company 33rd Annual Healthcare Conference

February 25, 2013 8:30 am | by The Associated Press | News | Comments

CardioDx, Inc., a pioneer in the field of cardiovascular genomic diagnostics, today announced that the company will present at the Cowen and Company 33rd Annual Healthcare Conference on Monday, March 4, 2013 at 10:00 a.m. ET at the Boston Marriott Copley Place in Boston.

Advertisement

Atossa Genetics Receives Warning Letter From the Food and Drug Administration

February 25, 2013 8:30 am | by The Associated Press | News | Comments

SEATTLE--(BUSINESS WIRE)--Feb 25, 2013--Atossa Genetics, Inc. (NASDAQ: ATOS) (“Atossa” or the “Company”) received a Warning Letter (“Letter”) from the FDA on February 21, 2013, regarding its Mammary Aspirate Specimen Cytology Test (MASCT) System and MASCT System Collection Test (together, the...

Lab21 and IntegraGen Partner to Develop New Colorectal Cancer Diagnostic

February 22, 2013 5:09 am | by The Associated Press | News | Comments

CAMBRIDGE, England--(BUSINESS WIRE)--Feb 22, 2013--Lab21 Limited, the global specialist in personalised medicine and clinical diagnostics, has entered into an agreement with IntegraGen, a leading player in the development and marketing of molecular diagnostic testing in autism and oncology, to...

Panagene Signs Off with Dako to Supply PNA Oligomer Component

February 22, 2013 3:01 am | by The Associated Press | News | Comments

DAEJEON, South Korea--(BUSINESS WIRE)--Feb 22, 2013--Panagene announced it has signed a supply agreement with Dako Denmark A/S to supply PNA oligomer key component for incorporation into Dako’s diagnostic or research products. Dako, an Agilent Technologies Company since June 2012, is a leading...

Humetrix Launches Cross-Platform iBlueButton Mobile Apps Enabling Patient-Physician Exchange of Health Records Between Apple and Android Devices

February 21, 2013 12:16 pm | News | Comments

Humetrix today introduced cross- platform capability for its award-winning iBlueButton® apps, enabling consumers and physicians for the first time to securely exchange health records and other clinical information at the point of care, regardless of whether they use an iPhone®, iPad® or Android® smartphone.

MPEG LA Continues to Expand Librassay® with Addition of WARF

February 21, 2013 10:00 am | by The Associated Press | News | Comments

DENVER--(BUSINESS WIRE)--Feb 21, 2013--MPEG LA today announced that the Wisconsin Alumni Research Foundation (WARF) has become a participating patent holder in Librassay, MPEG LA’s licensing supermarket of diagnostic and research tool patent rights for tests and assays, kits, tools and...

Advertisement

Positiveid Corporation Announces License of iglucose Technology for up to $2 Million

February 20, 2013 3:37 pm | by I-Micronews | News | Comments

PositiveID Corporation, a developer of biological detection and diagnostics solutions, announced it has entered into an agreement to license its iglucose™ technology to Smart Glucose Meter Corp. ("SGMC") for up to $2 million based on potential future revenues of glucose test strips sold by SGMC.

Flexpoint Announces Development Partnership with Haemoband Surgical, Ltd.

February 20, 2013 11:36 am | by The Associated Press | News | Comments

Flexpoint Sensor Systems, Inc. (OTCQB: FLXT) today announced that it is in advanced development on a disposable colonoscope application with Haemoband Surgical, Ltd. an Ireland-based company specializing in unique medical technologies. Phase I testing  has recently been satisfactorily...

Quest Diagnostics to Provide Nationwide Access to Natera's New Non-Invasive Prenatal Test

February 20, 2013 8:32 am | by The Associated Press | News | Comments

Quest Diagnostics (NYSE: DGX), the world's leading diagnostic information services company, and Natera, a leading innovator in prenatal genetic testing, today announced that Quest Diagnostics will offer physicians access to PanoramaT, a new non-invasive prenatal test developed by Natera. ...

OraQuick In-Home HIV Test Named a "Top Health Breakthrough of 2012" by Men's Health Magazine

February 19, 2013 2:58 pm | by Globe Newswire | News | Comments

OraSure Technologies, Inc. (Nasdaq:OSUR), the market leader in oral fluid diagnostics, announced today that the Company's OraQuick(R) In-Home HIV Test, the first ever in-home rapid infectious disease test made available directly to consumers, has been named a "Top Health Breakthrough of 2012" by Men's Health magazine.

New Handheld ECG Device Helps Physicians Identify Risks for Sudden Cardiac Arrest in Young Athletes

February 19, 2013 11:51 am | by The Associated Press | News | Comments

SEATTLE--(BUSINESS WIRE)--Feb 19, 2013--Cardea Associates, a company dedicated to improving heart health through product innovation and research, announces the launch of its new electrocardiographic (ECG) device, CardeaScreen. Specifically in-tune with normal conditions for the athletic heart,...

The Bank Where Doctors Can Stash Your Genome

February 19, 2013 12:00 am | by Massachusetts Institute of Technology | News | Comments

Genomic sequencing might be more common in medicine if doctors had a simple way to send for the test and keep track of the data. That’s the hope of Coriell Life Sciences in Camden, New Jersey, a startup that grew out of a partnership between the Coriell Institute for Medical Research and IBM.

Australian Government Invests in Detection and Management of Blinding Eye Disease and Diabetes Through Intelligent High Resolution Retinal Camera Development by Vision CRC

February 18, 2013 10:10 pm | by The Associated Press | News | Comments

The most advanced technology for use in real-time detection and assessment of common blinding eye disease and general health disorders will soon be available to the world with stimulus funding provided for development by the Australian Government's CRC Program. The imaging technology of the...

NewBridge Pharmaceuticals to Commercialize the verifi(R) Prenatal Test

February 14, 2013 1:15 pm | by The Associated Press | News | Comments

NewBridge Pharmaceuticals, a specialty therapeutics company commercializing pharmaceuticals, biologics, diagnostics and medical devices across the AfMET region (Middle East, Africa, Turkey & Caspian regions), today announced that the company has established an exclusive agreement with...

Frost & Sullivan Acknowledges that PKC's Biosensors are Expected to Become the New Industry Standard in Pathogen Testing

February 13, 2013 12:21 pm | by Bio-Medicine.Org | News | Comments

MOUNTAIN VIEW, Calif. , Feb. 13, 2013 /- Based on its recent analysis of the global biosensors market, Frost & Sullivan recognizes Pharmaco-Kinesis Corporation (PKC) with the 2013 Global Frost & Sullivan Award for New Product Innovation. The company has set a new standard in the biosensors market with its innovative, highly sensitive biosensor. This unique, multi-pathogen...

AB SCIEX Announces Company’s First In Vitro Diagnostic Device

February 12, 2013 12:00 pm | by The Associated Press | News | Comments

FRAMINGHAM, Mass.--(BUSINESS WIRE)--Feb 12, 2013--AB SCIEX, a global leader in analytical technologies, today introduced the AB SCIEX API 3200MD™ and 3200MD QTRAP®LC/MS/MS systems*, two devices that can be used to analyze trace levels of multiple compounds in human samples for diagnostic purposes....

Trovagene Announces Commercial Launch Timelines for HPV Carrier and Oncogene Mutation Tests

February 12, 2013 5:27 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO , Feb. 12, 2013 /- Trovagene, Inc. (NASDAQ:  TROV) today announced that the development of its proprietary, urine-based HPV carrier screening test is progressing well and the Company expects to achieve analytical and clinical validation of the test in its CLIA laboratory in March 2013. When validation is completed, the test will be available to clinicians and...

Over 19 Billion IVD Procedures Performed in 2012: Reports Kalorama

February 11, 2013 12:27 pm | by The Associated Press | News | Comments

In a sign that testing has become a significant part of clinical practice, Kalorama Information has noted that the total amount of in vitro diagnostic test procedures conducted globally reached 19.1 billion in 2012 and is expected to rise by 4.2% per year through 2017. The finding was made...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading